Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| METEORA CAPITAL, LLC | OCAX OCA Acquisition Corp. Class A Common Stock | 13G | 9.74% | Dec 31, 2023 | 2y |
| Bpifrance Participations S.A. | STM STMicroelectronics N.V. | 13G/A | 28.2% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | SCRM Screaming Eagle Acquisition Corp. Class A Ordinary Shares | 13G/A | 9.79% | Dec 31, 2023 | 2y |
| Rock Springs Capital Management LP | ACRS Aclaris Therapeutics, Inc. | 13G/A | 4.23% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | SGI Somnigroup International Inc. | 13G/A | 13.2% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | TARS Tarsus Pharmaceuticals, Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | SMNR Semnur Pharmaceuticals, Inc. | 13G | 6.85% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | PLRX Pliant Therapeutics, Inc. | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PRAA Pra Group Inc | 13G | 6.9% | Dec 31, 2023 | 2y |
| Atalaya Capital Management LP | SHFS SHF Holdings, Inc. | 13G/A | 3.25% | Dec 31, 2023 | 2y |
| CITADEL ADVISORS LLC | ACRO Acropolis Infrastructure Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Kynam Capital Management, LP | CLDX Celldex Therapeutics, Inc. | 13G | 5.5% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | RCAC Revelstone Capital Acquisition Corp. Class A Common Stock | 13G/A | 1.87% | Dec 31, 2023 | 2y |
| Suzano Holding S.A. | SUZ Suzano S.A. | 13G/A | 45% | Dec 31, 2023 | 2y |
| Phoenix Venture Partners II, LP | ABSI Absci Corp | 13G/A | 15.5% | Dec 31, 2023 | 2y |
| Forager Fund, L.P. | MCFT MasterCraft Boat Holdings, Inc. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Lincoln Park Capital Fund, LLC | CLRB Cellectar Biosciences, Inc. | 13G/A | 9.68% | Dec 31, 2023 | 2y |
| Long Focus Capital Management, LLC | ONIT Onity Group Inc. | 13G/A | 8.5% | Dec 31, 2023 | 2y |
| Fourthstone LLC | CCNB Coastal Carolina Bancshares, Inc. | 13G/A | 7.94% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | GNSS Genasys Inc. | 13G/A | 13.1% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | DSAQ Direct Selling Acquisition Corp. | 13G/A | 5.09% | Dec 31, 2023 | 2y |
| SOROS FUND MANAGEMENT LLC | LUCK Lucky Strike Entertainment Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | CDXS Codexis, Inc. | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | HAYN Haynes International, Inc. | 13G/A | 11.5% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | NVIV InVivo Therapeutics Holdings Corp | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | WING Wingstop Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | MDGL Madrigal Pharmaceuticals, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 5.88% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | VRDN Viridian Therapeutics, Inc.DE | 13G/A | 0% | Dec 31, 2023 | 2y |
| Lytton, Laurence W. | GIGA Giga-Tronics Inc | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | TLPH Talphera, Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | HWKZ Hawks Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | SVII Spring Valley Acquisition Corp. II Class A Ordinary Shares | 13G | 5.34% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | OKLO Oklo Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | TRTL TortoiseEcofin Acquisition Corp. III | 13G | 9.19% | Dec 31, 2023 | 2y |
| Charles Mosseri Marlio | XAIR Beyond Air, Inc. | 13G/A | 9.21% | Dec 31, 2023 | 2y |
| Commodore Capital LP | CELC Celcuity Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | AVTX Avalo Therapeutics, Inc. | 13G/A | 0.3% | Dec 31, 2023 | 2y |
| RBC Global Asset Management Inc. | UNTC UNIT CORP | 13G/A | 0% | Dec 31, 2023 | 2y |
| L. Lowry Baldwin | BWIN Baldwin Insurance Group, Inc. | 13G/A | 25.4% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CCCC C4 Therapeutics, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | M Macy's, Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | SYRE Spyre Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PRCT PROCEPT BioRobotics Corp | 13G | 7.3% | Dec 31, 2023 | 2y |
| David Barrett, individually and as trustee of the Barrett Family Trust, solely in such trust's capacity as the controlling member of Barrett Trust LLC | EXFY Expensify, Inc. | 13G/A | 7.1% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | CWAN Clearwater Analytics Holdings, Inc. | 13G/A | 2.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | XMTR Xometry, Inc. | 13G/A | 6% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | ABCL AbCellera Biologics Inc. | 13G | 7.9% | Dec 31, 2023 | 2y |